img

Global Sorafenib Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sorafenib Market Insights, Forecast to 2034

Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancer
Global Sorafenib market is expected to reach to US$ 896 million in 2024, with a positive growth of %, compared with US$ 915 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Sorafenib industry is evaluated to reach US$ 786.5 million in 2029. The CAGR will be -2.2% during 2024 to 2029.
Sorafenib is a targeted therapy used in the treatment of various cancers, including liver, kidney, and thyroid cancer. Factors driving market growth include the increasing incidence of these cancers, advancements in cancer treatment options, and the effectiveness of sorafenib in improving patient outcomes. The market is highly competitive, with several pharmaceutical companies manufacturing and marketing sorafenib. However, challenges such as high treatment costs, potential side effects, and the emergence of alternative therapies may hinder market growth. Nonetheless, the sorafenib market holds promising opportunities, driven by the growing global burden of cancer and the continuous research and development efforts to enhance the therapeutic potential of sorafenib.
Report Covers
This report presents an overview of global Sorafenib market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Sorafenib market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer
Natco Pharma
Cipla
Mylan
Segment by Type
Patented Drugs
Generic Drugs

Segment by Application


Kidney Cancer
Liver Cancer
Thyroid Cancer
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Sorafenib plant distribution, commercial date of Sorafenib, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Sorafenib introduction, etc. Sorafenib Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Sorafenib
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Sorafenib Product Introduction
1.2 Market by Type
1.2.1 Global Sorafenib Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Patented Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Sorafenib Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Kidney Cancer
1.3.3 Liver Cancer
1.3.4 Thyroid Cancer
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sorafenib Sales Estimates and Forecasts 2018-2029
2.2 Global Sorafenib Revenue by Region
2.2.1 Global Sorafenib Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Sorafenib Revenue by Region (2018-2024)
2.2.3 Global Sorafenib Revenue by Region (2024-2029)
2.2.4 Global Sorafenib Revenue Market Share by Region (2018-2029)
2.3 Global Sorafenib Sales Estimates and Forecasts 2018-2029
2.4 Global Sorafenib Sales by Region
2.4.1 Global Sorafenib Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Sorafenib Sales by Region (2018-2024)
2.4.3 Global Sorafenib Sales by Region (2024-2029)
2.4.4 Global Sorafenib Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Sorafenib Sales by Manufacturers
3.1.1 Global Sorafenib Sales by Manufacturers (2018-2024)
3.1.2 Global Sorafenib Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sorafenib in 2022
3.2 Global Sorafenib Revenue by Manufacturers
3.2.1 Global Sorafenib Revenue by Manufacturers (2018-2024)
3.2.2 Global Sorafenib Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Sorafenib Revenue in 2022
3.3 Global Key Players of Sorafenib, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Sorafenib Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Sorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Sorafenib, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Sorafenib, Product Offered and Application
3.8 Global Key Manufacturers of Sorafenib, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sorafenib Sales by Type
4.1.1 Global Sorafenib Historical Sales by Type (2018-2024)
4.1.2 Global Sorafenib Forecasted Sales by Type (2024-2029)
4.1.3 Global Sorafenib Sales Market Share by Type (2018-2029)
4.2 Global Sorafenib Revenue by Type
4.2.1 Global Sorafenib Historical Revenue by Type (2018-2024)
4.2.2 Global Sorafenib Forecasted Revenue by Type (2024-2029)
4.2.3 Global Sorafenib Revenue Market Share by Type (2018-2029)
4.3 Global Sorafenib Price by Type
4.3.1 Global Sorafenib Price by Type (2018-2024)
4.3.2 Global Sorafenib Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Sorafenib Sales by Application
5.1.1 Global Sorafenib Historical Sales by Application (2018-2024)
5.1.2 Global Sorafenib Forecasted Sales by Application (2024-2029)
5.1.3 Global Sorafenib Sales Market Share by Application (2018-2029)
5.2 Global Sorafenib Revenue by Application
5.2.1 Global Sorafenib Historical Revenue by Application (2018-2024)
5.2.2 Global Sorafenib Forecasted Revenue by Application (2024-2029)
5.2.3 Global Sorafenib Revenue Market Share by Application (2018-2029)
5.3 Global Sorafenib Price by Application
5.3.1 Global Sorafenib Price by Application (2018-2024)
5.3.2 Global Sorafenib Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Sorafenib Market Size by Type
6.1.1 US & Canada Sorafenib Sales by Type (2018-2029)
6.1.2 US & Canada Sorafenib Revenue by Type (2018-2029)
6.2 US & Canada Sorafenib Market Size by Application
6.2.1 US & Canada Sorafenib Sales by Application (2018-2029)
6.2.2 US & Canada Sorafenib Revenue by Application (2018-2029)
6.3 US & Canada Sorafenib Market Size by Country
6.3.1 US & Canada Sorafenib Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Sorafenib Sales by Country (2018-2029)
6.3.3 US & Canada Sorafenib Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Sorafenib Market Size by Type
7.1.1 Europe Sorafenib Sales by Type (2018-2029)
7.1.2 Europe Sorafenib Revenue by Type (2018-2029)
7.2 Europe Sorafenib Market Size by Application
7.2.1 Europe Sorafenib Sales by Application (2018-2029)
7.2.2 Europe Sorafenib Revenue by Application (2018-2029)
7.3 Europe Sorafenib Market Size by Country
7.3.1 Europe Sorafenib Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Sorafenib Sales by Country (2018-2029)
7.3.3 Europe Sorafenib Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Sorafenib Market Size
8.1.1 China Sorafenib Sales (2018-2029)
8.1.2 China Sorafenib Revenue (2018-2029)
8.2 China Sorafenib Market Size by Application
8.2.1 China Sorafenib Sales by Application (2018-2029)
8.2.2 China Sorafenib Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Sorafenib Market Size by Type
9.1.1 Asia Sorafenib Sales by Type (2018-2029)
9.1.2 Asia Sorafenib Revenue by Type (2018-2029)
9.2 Asia Sorafenib Market Size by Application
9.2.1 Asia Sorafenib Sales by Application (2018-2029)
9.2.2 Asia Sorafenib Revenue by Application (2018-2029)
9.3 Asia Sorafenib Sales by Region
9.3.1 Asia Sorafenib Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Sorafenib Revenue by Region (2018-2029)
9.3.3 Asia Sorafenib Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Sorafenib Market Size by Type
10.1.1 Middle East, Africa and Latin America Sorafenib Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Sorafenib Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Sorafenib Market Size by Application
10.2.1 Middle East, Africa and Latin America Sorafenib Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Sorafenib Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Sorafenib Sales by Country
10.3.1 Middle East, Africa and Latin America Sorafenib Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Sorafenib Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Sorafenib Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Overview
11.1.3 Bayer Sorafenib Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bayer Sorafenib Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Natco Pharma
11.2.1 Natco Pharma Company Information
11.2.2 Natco Pharma Overview
11.2.3 Natco Pharma Sorafenib Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Natco Pharma Sorafenib Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Natco Pharma Recent Developments
11.3 Cipla
11.3.1 Cipla Company Information
11.3.2 Cipla Overview
11.3.3 Cipla Sorafenib Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Cipla Sorafenib Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cipla Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Sorafenib Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Sorafenib Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sorafenib Industry Chain Analysis
12.2 Sorafenib Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sorafenib Production Mode & Process
12.4 Sorafenib Sales and Marketing
12.4.1 Sorafenib Sales Channels
12.4.2 Sorafenib Distributors
12.5 Sorafenib Customers
13 Market Dynamics
13.1 Sorafenib Industry Trends
13.2 Sorafenib Market Drivers
13.3 Sorafenib Market Challenges
13.4 Sorafenib Market Restraints
14 Key Findings in The Global Sorafenib Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Sorafenib Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Patented Drugs
Table 3. Major Manufacturers of Generic Drugs
Table 4. Global Sorafenib Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Sorafenib Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Sorafenib Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Sorafenib Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Sorafenib Revenue Market Share by Region (2018-2024)
Table 9. Global Sorafenib Revenue Market Share by Region (2024-2029)
Table 10. Global Sorafenib Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Sorafenib Sales by Region (2018-2024) & (K Units)
Table 12. Global Sorafenib Sales by Region (2024-2029) & (K Units)
Table 13. Global Sorafenib Sales Market Share by Region (2018-2024)
Table 14. Global Sorafenib Sales Market Share by Region (2024-2029)
Table 15. Global Sorafenib Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Sorafenib Sales Share by Manufacturers (2018-2024)
Table 17. Global Sorafenib Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Sorafenib Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Sorafenib, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Sorafenib Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Sorafenib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Sorafenib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sorafenib as of 2022)
Table 23. Global Key Manufacturers of Sorafenib, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Sorafenib, Product Offered and Application
Table 25. Global Key Manufacturers of Sorafenib, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sorafenib Sales by Type (2018-2024) & (K Units)
Table 28. Global Sorafenib Sales by Type (2024-2029) & (K Units)
Table 29. Global Sorafenib Sales Share by Type (2018-2024)
Table 30. Global Sorafenib Sales Share by Type (2024-2029)
Table 31. Global Sorafenib Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Sorafenib Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Sorafenib Revenue Share by Type (2018-2024)
Table 34. Global Sorafenib Revenue Share by Type (2024-2029)
Table 35. Sorafenib Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Sorafenib Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Sorafenib Sales by Application (2018-2024) & (K Units)
Table 38. Global Sorafenib Sales by Application (2024-2029) & (K Units)
Table 39. Global Sorafenib Sales Share by Application (2018-2024)
Table 40. Global Sorafenib Sales Share by Application (2024-2029)
Table 41. Global Sorafenib Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Sorafenib Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Sorafenib Revenue Share by Application (2018-2024)
Table 44. Global Sorafenib Revenue Share by Application (2024-2029)
Table 45. Sorafenib Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Sorafenib Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Sorafenib Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Sorafenib Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Sorafenib Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Sorafenib Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Sorafenib Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Sorafenib Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Sorafenib Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Sorafenib Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Sorafenib Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Sorafenib Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Sorafenib Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Sorafenib Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Sorafenib Sales by Country (2024-2029) & (K Units)
Table 60. Europe Sorafenib Sales by Type (2018-2024) & (K Units)
Table 61. Europe Sorafenib Sales by Type (2024-2029) & (K Units)
Table 62. Europe Sorafenib Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Sorafenib Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Sorafenib Sales by Application (2018-2024) & (K Units)
Table 65. Europe Sorafenib Sales by Application (2024-2029) & (K Units)
Table 66. Europe Sorafenib Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Sorafenib Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Sorafenib Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Sorafenib Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Sorafenib Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Sorafenib Sales by Country (2018-2024) & (K Units)
Table 72. Europe Sorafenib Sales by Country (2024-2029) & (K Units)
Table 73. China Sorafenib Sales by Type (2018-2024) & (K Units)
Table 74. China Sorafenib Sales by Type (2024-2029) & (K Units)
Table 75. China Sorafenib Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Sorafenib Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Sorafenib Sales by Application (2018-2024) & (K Units)
Table 78. China Sorafenib Sales by Application (2024-2029) & (K Units)
Table 79. China Sorafenib Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Sorafenib Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Sorafenib Sales by Type (2018-2024) & (K Units)
Table 82. Asia Sorafenib Sales by Type (2024-2029) & (K Units)
Table 83. Asia Sorafenib Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Sorafenib Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Sorafenib Sales by Application (2018-2024) & (K Units)
Table 86. Asia Sorafenib Sales by Application (2024-2029) & (K Units)
Table 87. Asia Sorafenib Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Sorafenib Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Sorafenib Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Sorafenib Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Sorafenib Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Sorafenib Sales by Region (2018-2024) & (K Units)
Table 93. Asia Sorafenib Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Sorafenib Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Sorafenib Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Sorafenib Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Sorafenib Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Sorafenib Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Sorafenib Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Sorafenib Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Sorafenib Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Sorafenib Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Sorafenib Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Sorafenib Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Sorafenib Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Sorafenib Sales by Country (2024-2029) & (K Units)
Table 107. Bayer Company Information
Table 108. Bayer Description and Major Businesses
Table 109. Bayer Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Bayer Sorafenib Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bayer Recent Developments
Table 112. Natco Pharma Company Information
Table 113. Natco Pharma Description and Major Businesses
Table 114. Natco Pharma Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Natco Pharma Sorafenib Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Natco Pharma Recent Developments
Table 117. Cipla Company Information
Table 118. Cipla Description and Major Businesses
Table 119. Cipla Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Cipla Sorafenib Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Cipla Recent Developments
Table 122. Mylan Company Information
Table 123. Mylan Description and Major Businesses
Table 124. Mylan Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Mylan Sorafenib Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Mylan Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Sorafenib Distributors List
Table 130. Sorafenib Customers List
Table 131. Sorafenib Market Trends
Table 132. Sorafenib Market Drivers
Table 133. Sorafenib Market Challenges
Table 134. Sorafenib Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Sorafenib Product Picture
Figure 2. Global Sorafenib Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Sorafenib Market Share by Type in 2022 & 2029
Figure 4. Patented Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Sorafenib Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Sorafenib Market Share by Application in 2022 & 2029
Figure 8. Kidney Cancer
Figure 9. Liver Cancer
Figure 10. Thyroid Cancer
Figure 11. Other
Figure 12. Sorafenib Report Years Considered
Figure 13. Global Sorafenib Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Sorafenib Revenue 2018-2029 (US$ Million)
Figure 15. Global Sorafenib Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Sorafenib Revenue Market Share by Region (2018-2029)
Figure 17. Global Sorafenib Sales 2018-2029 ((K Units)
Figure 18. Global Sorafenib Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Sorafenib Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Sorafenib Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Sorafenib Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Sorafenib Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Sorafenib Sales YoY (2018-2029) & (K Units)
Figure 24. China Sorafenib Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Sorafenib Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Sorafenib Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Sorafenib Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Sorafenib Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Sorafenib Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Sorafenib in the World: Market Share by Sorafenib Revenue in 2022
Figure 31. Global Sorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Sorafenib Sales Market Share by Type (2018-2029)
Figure 33. Global Sorafenib Revenue Market Share by Type (2018-2029)
Figure 34. Global Sorafenib Sales Market Share by Application (2018-2029)
Figure 35. Global Sorafenib Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Sorafenib Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Sorafenib Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Sorafenib Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Sorafenib Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Sorafenib Revenue Share by Country (2018-2029)
Figure 41. US & Canada Sorafenib Sales Share by Country (2018-2029)
Figure 42. U.S. Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Sorafenib Sales Market Share by Type (2018-2029)
Figure 45. Europe Sorafenib Revenue Market Share by Type (2018-2029)
Figure 46. Europe Sorafenib Sales Market Share by Application (2018-2029)
Figure 47. Europe Sorafenib Revenue Market Share by Application (2018-2029)
Figure 48. Europe Sorafenib Revenue Share by Country (2018-2029)
Figure 49. Europe Sorafenib Sales Share by Country (2018-2029)
Figure 50. Germany Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 51. France Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 52. UK Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 55. China Sorafenib Sales Market Share by Type (2018-2029)
Figure 56. China Sorafenib Revenue Market Share by Type (2018-2029)
Figure 57. China Sorafenib Sales Market Share by Application (2018-2029)
Figure 58. China Sorafenib Revenue Market Share by Application (2018-2029)
Figure 59. Asia Sorafenib Sales Market Share by Type (2018-2029)
Figure 60. Asia Sorafenib Revenue Market Share by Type (2018-2029)
Figure 61. Asia Sorafenib Sales Market Share by Application (2018-2029)
Figure 62. Asia Sorafenib Revenue Market Share by Application (2018-2029)
Figure 63. Asia Sorafenib Revenue Share by Region (2018-2029)
Figure 64. Asia Sorafenib Sales Share by Region (2018-2029)
Figure 65. Japan Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 69. India Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Sorafenib Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Sorafenib Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Sorafenib Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Sorafenib Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Sorafenib Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Sorafenib Sales Share by Country (2018-2029)
Figure 76. Brazil Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Sorafenib Revenue (2018-2029) & (US$ Million)
Figure 81. Sorafenib Value Chain
Figure 82. Sorafenib Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries